Medicines Australia welcomes greater input into PBS advisory committee

Trade body Medicines Australia has welcomed the extended 10 week publication time for the agenda for Pharmaceutical Benefits Advisory Committee meetings that comes into effect today.

The agenda for each PBAC meeting will now be published 10 weeks prior to the meeting, as opposed to the six weeks that had been normal practice until today.

Medicines Australia chief executive Brendan Shaw said: “Medicines Australia supports the longer time period of publication of the PBAC agenda prior to each meeting. It means consumers, consumer groups, and members of the general public will now have more time to prepare submissions and make comments to the PBAC on new medicines and vaccines seeking listing on the Pharmaceutical Benefits Scheme.”